Search research articles
Contact Us
Filters
Showing results (421-430 of 436) with videos related to
Page
of 44
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance
Stephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene Therapy
Brandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to Radiation
Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
The Journal of Clinical Investigation
|
September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Santiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
NPJ Precision Oncology
|
August 14, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon
Cameron Crowell, Ziwen Zhu, Yingxiang Li, et al.
Science Advances
|
September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy
Mahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
The Lancet. Oncology
|
September 1, 2023
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial
Yoshie Umemura, Daniel Orringer, Larry Junck, et al.
Research Square
|
September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target
Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
ACS Nano
|
May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy
Mahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Neuro-Oncology
|
May 23, 2022
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma
Dana Messinger, Micah K Harris, Jessica R Cummings, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 436) with videos related to
Sort By:
Page
of 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance
Stephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene Therapy
Brandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to Radiation
Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
The Journal of Clinical Investigation
|
September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Santiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
NPJ Precision Oncology
|
August 14, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon
Cameron Crowell, Ziwen Zhu, Yingxiang Li, et al.
Science Advances
|
September 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy
Mahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari, et al.
The Lancet. Oncology
|
September 1, 2023
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial
Yoshie Umemura, Daniel Orringer, Larry Junck, et al.
Research Square
|
September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target
Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
ACS Nano
|
May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy
Mahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Neuro-Oncology
|
May 23, 2022
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma
Dana Messinger, Micah K Harris, Jessica R Cummings, et al.
Page
of 44